LB
63
-4
AAPL
45
3
ROK
67
5
FDX
54
14
TXT
62
2
OI
43
-2
CHRW
67
3
AIZ
78
2
RSG
77
4
IP
70
-3
EXPE
96
-3
CI
52
-7
SIG
47
-2
TAP
64
4
AIG
47
6
UA
57
4
C
62
-3
GOOGL
59
-8
INTC
49
16
DGX
48
-3
LB
63
-4
AAPL
45
3
ROK
67
5
FDX
54
14
TXT
62
2
OI
43
-2
CHRW
67
3
AIZ
78
2
RSG
77
4
IP
70
-3
EXPE
96
-3
CI
52
-7
SIG
47
-2
TAP
64
4
AIG
47
6
UA
57
4
C
62
-3
GOOGL
59
-8
INTC
49
16
DGX
48
-3
Financhill
Back

Biodexa Pharmaceuticals PLC Vs. Neurogene Industry Stock Comparison

Sell
20

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
4.88
Seasonality Move:
-24.35%
Sell
5

NGNE
Neurogene

Last Price:
39.91
Seasonality Move:
50.43%
Sell
20
Biodexa Pharmaceuticals PLC (BDRX) is a Sell

Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?

  • The current Biodexa Pharmaceuticals PLC [BDRX] share price is $4.85. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BDRX Stock Price Chart

What is Biodexa Pharmaceuticals PLC's stock price today?

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $39.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

BDRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 35.96 Sell
Chaikin Money Flow: -3676 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.03 - 6.65) Sell
Bollinger Bands (100): (-0.27 - 4.53) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 39.1 Sell
Chaikin Money Flow: -346626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.29 - 61.53) Sell
Bollinger Bands (100): (34.11 - 50.51) Sell

BDRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.37 Sell
20-day SMA: 6.04 Sell
50-day SMA: 3.53 Buy
200-day SMA: 1.66 Buy
8-day EMA: 5.34 Sell
20-day EMA: 5.37 Sell
50-day EMA: 4.13 Buy
200-day EMA: 12.72 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Sell
20-day SMA: 53.17 Sell
50-day SMA: 46.66 Sell
200-day SMA: 38.93 Buy
8-day EMA: 54.03 Sell
20-day EMA: 53.18 Sell
50-day EMA: 48.36 Sell
200-day EMA: 38.47 Buy

Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Biodexa Pharmaceuticals PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):